Log in to save to my catalogue

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer...

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_200951882

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

About this item

Full title

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2009-11, Vol.10 (11), p.1063-1069

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background The best chemotherapy regimen for metastatic gastric cancer is uncertain, but promising findings have been reported with irinotecan plus cisplatin and S-1 (tegafur, 5-chloro-2,4-dihydropyrimidine, and potassium oxonate). We aimed to investigate the superiority of irinotecan plus cisplatin and non-inferiority of S-1 compared with...

Alternative Titles

Full title

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_200951882

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_200951882

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(09)70259-1

How to access this item